The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy

Published:2019-02 Issue:2 Volume:40 Page:142-158
ISSN:1471-4906
Container-title:Trends in Immunology
language:en
Short-container-title:Trends in Immunology

Author:

Souza-Fonseca-Guimaraes Fernando,Cursons Joseph,Huntington Nicholas D.

Funder

National Health and Medical Research Council

National Breast Cancer Foundation

Cure Cancer Australia

Melanoma Research

Cancer Research Institute

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference115 articles.

1. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial;Hodi;Lancet Oncol.,2018

2. Understanding the tumor immune microenvironment (TIME) for effective therapy;Binnewies;Nat. Med.,2018

3. Adaptive immune resistance: how cancer protects from immune attack;Ribas;Cancer Discov.,2015

4. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov.,2018

5. Bench to bedside: NK cells and control of metastasis;Krasnova;Clin. Immunol.,2017

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy;Immunology & Cell Biology;2024-09-13

2. The stress response regulator HSF1 modulates natural killer cell anti-tumour immunity;Nature Cell Biology;2024-09-02

3. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

4. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review;Frontiers in Immunology;2024-08-27

5. Biomaterials‐Boosted Immunotherapy for Osteosarcoma;Advanced Healthcare Materials;2024-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3